FDA Inspection 1147144 — Manhattan Drug Co. Inc

Manhattan Drug Co. Inc — FEI 2219579

The FDA completed an inspection of Manhattan Drug Co. Inc on Jul 22, 2021 in Hillside, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 22, 2021
Fiscal Year
2021
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Hillside, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.